Sanofi (SNYNF) Thursday said it is in discussions with private equity company CD&R to sell 50 percent controlling stake in its consumer healthcare business, Opella.
"Opella's journey to independence aligns with Sanofi's strategy to focus on innovative medicines and vaccines. Opella already operates today as a standalone business unit within Sanofi, with dedicated resources for R&D, production, digital, and with its own sustainability roadmap," the company said in a statement.
In 2023, Opella's sales had grown 6.3 percent at constant exchange rates.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.